The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

Vikram Malik Biography and Net Worth

Director of Evolus

Mr. Malik has served as a member and the Chairman of our board of directors since January 2018. Mr. Malik has served as a member of Alphaeon’s board of directors since April 2014 and of the board of managers of Alphaeon 1, LLC since January 2020. Since May 2013, Mr. Malik has served as the Managing Partner of Strathspey Crown Holdings Group, LLC. From August 2011 to May 2013, Mr. Malik served as Vice Chairman, Investment Banking for Deutsche Bank Securities, Inc. From November 2010 to August 2011, Mr. Malik served as a Managing Director in the Healthcare Corporate and Investment Banking Group of Merrill Lynch, Pierce, Fenner & Smith Incorporated. From June 2000 to November 2010, Mr. Malik served as the Managing Director of Banc of America Securities, LLC. Mr. Malik received a B.A. in Economics from Delhi University and an M.B.A. from Boston University Graduate School of Management.

What is Vikram Malik's net worth?: The estimated net worth of Vikram Malik is at least $3.37 million as of August 15th, 2023. Mr. Malik owns 275,550 shares of Evolus stock worth more than $3,372,732 as of May 1st. This net worth evaluation does not reflect any other investments that Mr. Malik may own. Learn More about Vikram Malik's net worth.
How do I contact Vikram Malik?: The corporate mailing address for Mr. Malik and other Evolus executives is 520 Newport Center Dr. Suite 1200, Newport Beach CA, 92660. Evolus can also be reached via phone at (949) 284-4555 and via email at [email protected]. Learn More on Vikram Malik's contact information.
Has Vikram Malik been buying or selling shares of Evolus?: Vikram Malik has not been actively trading shares of Evolus during the last ninety days. Most recently, on Tuesday, August 15th, Vikram Malik bought 174,967 shares of Evolus stock. The stock was acquired at an average cost of $7.41 per share, with a total value of $1,296,505.47. Following the completion of the transaction, the director now directly owns 275,550 shares of the company's stock, valued at $2,041,825.50. Learn More on Vikram Malik's trading history.
Who are Evolus' active insiders?: Evolus' insider roster includes Rui Avelar (Insider), Vikram Malik (Director), and David Moatazedi (Insider). Learn More on Evolus' active insiders.
Are insiders buying or selling shares of Evolus?: During the last twelve months, Evolus insiders bought shares 1 times. They purchased a total of 174,967 shares worth more than $1,296,505.47. During the last twelve months, insiders at the sold shares 11 times. They sold a total of 1,839,669 shares worth more than $14,387,161.85. The most recent insider tranaction occured on March, 27th when insider David Moatazedi sold 6,236 shares worth more than $86,430.96. Insiders at Evolus own 5.4% of the company. Learn More about insider trades at Evolus.
Information on this page was last updated on 3/27/2024.

Vikram Malik Insider Trading History at Evolus

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2023	Buy	174,967	$7.41	$1,296,505.47	275,550
8/23/2021	Sell	26,077	$11.00	$286,847.00
8/19/2021	Sell	11,962	$10.50	$125,601.00
8/17/2021	Sell	42,083	$10.06	$423,354.98
6/3/2019	Buy	1,298,701	$19.25	$24,999,994.25
12/17/2018	Buy	7,800	$13.04	$101,712.00
6/14/2018	Buy	8,600	$28.88	$248,368.00

Vikram Malik Buying and Selling Activity at Evolus

Evolus Company Overview

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Today's Range

Now: $12.62

$12.01

$12.68

50 Day Range

MA: $13.32

$11.43

$14.91

2 Week Range

Now: $12.62

$7.07

$15.43

Volume

611,583 shs

Average Volume

616,625 shs

Market Capitalization

$789.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him